Our office in Chanhassen, Minnesota services and supports a distribution network throughout North America, offering surgeons access to our clinically proven device for reconstructing the Acromioclavicular joint after injury.
With over 11,000 implantations globally, Lockdown stabilization for Acromioclavicular joint disruption is the market leader in many countries worldwide. Lockdown gained FDA approval in February 2011 and is available to fix acute ACJ disruption as a standalone device and augmented with an Allograft or Autograft to fix chronic ACJ disruption.
We are registered with BSI and hold Certificate no. MD 534510 and operate a Quality Management System which complies with the requirements of ISO 13485:2003.
We are registered with the FDA in the USA, Registration no. 8020712 FEI No. 3008237817.
Our products are CE-marked Certificate No. CE 00403.
Our VAT number is 933 8359 95.